Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Brought to you by:
Biotech
Incyte inks deal with Edison to train AI through drug discovery
Incyte and Edison Scientific have signed a collaboration to employ Edison’s AI scientist, Kosmos, in Incyte’s drug discovery and development work.
Will Maddox
May 19, 2026 10:30am
Roche inks Nvidia expansion to bolster AI factory
Mar 16, 2026 5:58pm
How Jeff Legos builds Pfizer’s oncology future
Mar 4, 2026 2:00pm
Angelini nocks an AI arrow with $120M Quiver deal
Feb 23, 2026 11:04am
BMS and Evinova pen global development partnership
Feb 9, 2026 2:33pm
Lilly joins platform biotech's Repertoire with $1.9B deal
Jan 29, 2026 6:30am
